Clinical Trial Update: A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial MK-8690-002 evaluating efficacy and safety of MK-8690 in moderately to severely active ulcerative colitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• MK-8690

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Colitis Ulcerative, Ulcerative Colitis | Phase 2 | Status: RECRUITING